It has been recently observed that SIRT4 inhibition increases mitochondrial function and fatty acid oxidation in liver and muscle cells, suggesting therapeutic benefits for metabolic diseases such as type 2 diabetes [32]. The gene discussed is SIRT4; the disease is metabolic disease.